why choose us

First received: October 28, 2022

Clinical Trial: Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Obstructive Pulmonary Disease

Study Type: INTERVENTIONAL


Official Title: The Influence of Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Patients With Chronic Obstructive Pulmonary Disease

Brief Summary: Cardiovascular health is a critical problem in patients with chronic obstructive pulmonary disease (COPD).Existing literature suggests oxidative stress from the mitochondria c driving some of the poor health outcomes in COPD.MitoQ is a mitochondrial-targeted antioxidant that has shown promise in improving cardiovascular outcomes in similar populations.Thus the purpose of this study is to test if MitoQ can improve cardiovascular health in COPD.

Read more